StockWatch
·
Major Chemicals
Quarterly ResultAug 5, 2026, 04:45 PM

Albemarle Q2 Net Income $479.96M, EPS $3.52; Divests Refining Solutions

AI Summary

Albemarle reported a substantial increase in net income and EPS for Q2 2026, with net income attributable to common shareholders rising to $438.27 million from a loss in the prior year. This strong performance was supported by a 31% increase in net sales. The company also completed the divestment of its Refining Solutions business for $525.2 million and its Eurecat S.A. interest for $123 million, using proceeds to significantly reduce long-term debt by over $1.3 billion and increase its quarterly dividend.

Key Highlights

  • Net sales for Q2 2026 increased 31% to $1.74 billion from $1.33 billion in Q2 2025.
  • Net income attributable to Albemarle Corp. rose to $479.96 million in Q2 2026 from $22.90 million in Q2 2025.
  • Diluted EPS was $3.52 in Q2 2026, compared to ($0.16) in Q2 2025.
  • Divested Refining Solutions business for $525.2 million cash and Eurecat S.A. for $123 million cash.
  • Reduced long-term debt by over $1.3 billion, recording a $12.5 million gain on extinguishment.
  • Declared a quarterly cash dividend of $0.41 per share, an increase from $0.405.
  • Net cash provided by operating activities for H1 2026 was $1.06 billion, up from $538.18 million.
  • Equity in net income of unconsolidated investments (Windfield) increased to $165.84 million in Q2 2026.